Rachelle Gordon is a cannabis journalist at GreenState.com. She specializes in cannabis and psychedelics, covering topics such as cannabidiol (CBD), cannabis business, and psychedelic research. Rachelle has been featured in Cannabis & Tech Today, Cannabis Now, Psychedelic Spotlight, High Times, and many other prominent publications.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Rachelle's coverage primarily focuses on the cannabis industry, with a mix of cultural and regulatory topics. Given this focus, she would likely be receptive to pitches from experts who can provide insights into trends and developments within the cannabis space.
As Rachelle covers a variety of themes such as food & beverage, healthcare & pharmaceuticals, and house & home in relation to cannabis, she may also be interested in expert commentary that connects these areas with the cannabis industry.
Since there is no specific geographic focus mentioned for Rachelle's articles, sources from various locations could potentially find relevance in her coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
While news of rescheduling has dominated the U.S. cannabis news cycle, discerning eyes are also looking overseas.
The hemp clock is ticking. Lawmakers have less than six months before a new law changing the federal definition of hemp is set to take effect. If implemented as written, the change would likely remove most hemp-derived products, including full-spectrum CBD oil and THC beverages, from the legal market. Now, three separate hemp amendments have been filed in Congress meant to preserve most of the industry.
Medical marijuana is legal in most states, but the FDA has yet to approve most therapies. A new THC drug for pain could be one of the first.
Medical marijuana has been legalized in the majority of states, and state-licensed medical cannabis is now officially Schedule III.
Intoxicating hemp has been a topic of hot debate. The Drug Enforcement Administration (DEA) recently ruled that one hemp-derived cannabinoid, hexahydrocannabinol, or HHC, is a Schedule I controlled substance.
The Trump administration is yet again calling on Congress to ensure Americans can continue to access CBD products despite a looming ban.
New York is cracking down on cannabis inversion with unprecedented legislation meant to tackle the practice head on.
By: Rachelle Gordon
Cannabis policy is becoming a more prominent campaign issue for politicians across the country. Illinois Lt. Gov. Juliana Stratton, the Democratic nominee for U.S.
The Supreme Court has ruled in favor of a Texas man, deciding consuming cannabis does not disqualify someone from owning guns.
The DEA cannabis hearing to debate full rescheduling seems one-sided, with all pro-plant applicants denied attendance.
